Top Markets
Coin of the day
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.

Silverback Therapeutics, Inc.

SBTX
Peringkat dalam Saham #12786
Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to... Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to devising tissue-specific drug candidates aimed at addressing chronic viral infections, various cancers, and other significant medical conditions. Among its pipeline, SBT8230 stands out as a treatment for chronic hepatitis B virus, working by stimulating an antiviral immune response through the precise activation of TLR8 within the liver. The company was founded in 2016 and maintains its principal offices in Seattle, Washington.
Harga Saham
$5.87
Terakhir disinkronkan: 2022-11-08
Kapitalisasi Pasar
$550.43M
Perubahan (1 hari)
1.03%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Silverback Therapeutics, Inc. (SBTX)

Kategori

Harga SBTX dengan kapitalisasi pasar B
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
SBTX
$5.87
Kapitalisasi pasar dari Silverback Therapeutics, Inc.(SBTX)
Kapitalisasi Pasar: $550.43M
Per August 2026, Silverback Therapeutics, Inc. memiliki kapitalisasi pasar sebesar $550.43M. Ini menjadikan Silverback Therapeutics, Inc. sebagai perusahaan 12786th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Silverback Therapeutics, Inc. dari 2020 hingga 2026
SBTX dibandingkan dengan 5 teratas stocks paling populer
Harga SBTX Aset B Pasar B Hasil
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$56,135.85 $550.43M
$5.264T +956,217.67%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$50,136.16 $550.43M
$4.701T +854,008.32%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$44,546.98 $550.43M
$4.177T +758,792.33%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$40,710.19 $550.43M
$3.817T +693,429.61%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$30,567.68 $550.43M
$2.866T +520,644.20%